$FCSC Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-
<ticker> <company> announces positive feedback from type b end - of - phase <number> meeting with fda on phase <number> clinical trial design for <ticker>